ID
42250
Descripción
Study ID: 104864/410 Clinical Study ID: 104864/410 Study Title: A randomised open-label multicentre Phase II study to evaluate the safety and efficacy of intravenous topotecan given with either cisplatin or etoposide every 21 days as first-line therapy in patients with extensive-disease (ED) small-cell lung cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Study Indication: Lung Cancer
Palabras clave
Versiones (1)
- 18/4/21 18/4/21 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
18 de abril de 2021
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Safety and efficacy of topotecan in patients with extensive-disease small-cell lung cancer (104864/410)
Screening - Prior an Concomitant Medication; Telephone Randomisation
Descripción
Prior and Concomitant Medication
Alias
- UMLS CUI-1
- C2826257
- UMLS CUI-2
- C2347852
Descripción
If "Yes" please record details below. Where appropriate, medical conditions should be recorded in the Significant Medical/ Surgical History and Physical examination section, utilising the same terminology. Record PM for prophylactic treatment with the Medical Condition for prophylactically administered medications.
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C2826257
Descripción
Prior and Concomitant Medication
Alias
- UMLS CUI-1
- C2826257
- UMLS CUI-2
- C2347852
Descripción
Trade Name preferred
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0013227
Descripción
Total Daily Dose
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2348070
- UMLS CUI [1,2]
- C0013227
Descripción
Administration Route
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0013153
Descripción
Medical Condition
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0012634
Descripción
Medication Start Date
Tipo de datos
date
Alias
- UMLS CUI [1]
- C2826734
Descripción
Medication End Date
Tipo de datos
date
Alias
- UMLS CUI [1]
- C2826744
Descripción
Medication Continuing
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0549178
Descripción
Telephone Randomisation
Alias
- UMLS CUI-1
- C0039457
- UMLS CUI-2
- C0034656
Descripción
If "Yes" please record the patient's randomisation number
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C1514821
- UMLS CUI [2]
- C0034656
- UMLS CUI [3]
- C0039457
Descripción
Randomisation Number
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0034656
- UMLS CUI [1,2]
- C0237753
Descripción
Patient's randomised treatment arm
Tipo de datos
text
Alias
- UMLS CUI [1]
- C1522541
Similar models
Screening - Prior an Concomitant Medication; Telephone Randomisation
C2347852 (UMLS CUI-2)
C2347852 (UMLS CUI-2)
C0013227 (UMLS CUI [1,2])
C0549178 (UMLS CUI [1,2])
C0034656 (UMLS CUI-2)
C0034656 (UMLS CUI [2])
C0039457 (UMLS CUI [3])
C0237753 (UMLS CUI [1,2])
Sin comentarios